18-FEB-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES -- ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 1066 14 730 107 1303 182 1108
ERLYTX 78 0 0 2 24 5 30
GI 186 1 52 14 170 22 134
GU 406 3 157 22 268 42 256
LEUK 137 3 157 8 97 17 103
LUNG 183 3 157 21 256 32 195
LYMPH 393 6 313 40 487 56 341
MELAN 246 0 0 0 0 0 0
MMYEL 117 0 0 5 61 11 67
MULT 23 0 0 0 0 1 6
OTHER 43 0 0 4 49 8 49
PREV 2 0 0 0 0 0 0
SXQOL 2 0 0 0 0 0 0
Total 2882 30 1566 223 2715 376 2289

18-FEB-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

NON-THERAPEUTIC STUDIES -- ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
  1 1 52 1 12 1 6
CCD 127 3 157 20 244 30 183
ERLYTX 10 0 0 0 0 0 0
GU 1 0 0 1 12 1 6
LEUK 623 9 470 55 670 93 566
LUNG 335 8 417 35 426 56 341
OTHER 34 0 0 1 12 2 12
PEOLC 121 0 0 1 12 4 24
PREV 227 2 104 22 268 39 237
SXQOL 575 11 574 51 621 84 511
Total 2054 34 1774 187 2277 310 1886

18-FEB-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
  1 1 52 1 12 1 6
BREAST 1066 14 730 107 1303 182 1108
CCD 127 3 157 20 244 30 183
ERLYTX 88 0 0 2 24 5 30
GI 186 1 52 14 170 22 134
GU 407 3 157 23 280 43 262
LEUK 760 12 626 63 767 110 670
LUNG 518 11 574 56 682 88 536
LYMPH 393 6 313 40 487 56 341
MELAN 246 0 0 0 0 0 0
MMYEL 117 0 0 5 61 11 67
MULT 23 0 0 0 0 1 6
OTHER 77 0 0 5 61 10 61
PEOLC 121 0 0 1 12 4 24
PREV 229 2 104 22 268 39 237
SXQOL 577 11 574 51 621 84 511
Total 4936 64 3339 410 4992 686 4176

18-FEB-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES - ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 686 8 417 73 889 129 785
ERLYTX 44 0 0 1 12 3 18
GI 133 0 0 9 110 14 85
GU 337 2 104 14 170 34 207
LEUK 84 2 104 7 85 13 79
LUNG 115 2 104 14 170 21 128
LYMPH 254 4 209 24 292 37 225
MELAN 155 0 0 0 0 0 0
MMYEL 72 0 0 2 24 6 37
MULT 8 0 0 0 0 0 0
OTHER 43 0 0 4 49 8 49
PREV 2 0 0 0 0 0 0
SXQOL 2 0 0 0 0 0 0
Total 1935 18 938 148 1801 265 1613

18-FEB-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

NON-THERAPEUTIC STUDIES - ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
  1 1 52 1 12 1 6
CCD 112 3 157 18 219 26 158
ERLYTX 10 0 0 0 0 0 0
GU 1 0 0 1 12 1 6
LEUK 262 2 104 19 231 33 201
LUNG 211 3 157 20 244 31 189
OTHER 34 0 0 1 12 2 12
PEOLC 86 0 0 1 12 4 24
PREV 227 2 104 22 268 39 237
SXQOL 393 6 313 36 438 61 371
Total 1337 17 887 119 1448 198 1204

18-FEB-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
  1 1 52 1 12 1 6
BREAST 879 7 365 90 1096 159 968
CCD 147 3 157 17 207 30 183
ERLYTX 54 0 0 1 12 3 18
GI 137 0 0 8 97 14 85
GU 360 2 104 17 207 40 244
LEUK 346 4 209 26 317 46 280
LUNG 333 5 261 36 438 58 353
LYMPH 254 4 209 24 292 37 225
MELAN 155 0 0 0 0 0 0
MMYEL 66 0 0 2 24 6 37
MULT 30 2 104 5 61 7 43
OTHER 240 1 52 9 110 23 140
PEOLC 89 0 0 1 12 5 30
PREV 229 2 104 22 268 39 237
SXQOL 395 6 313 36 438 61 371
Total 3715 37 1930 295 3591 529 3220

18-FEB-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES COORDINATED BY SWOG

ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 879 12 626 82 998 140 852
ERLYTX 74 0 0 2 24 5 30
GI 108 1 52 9 110 14 85
GU 249 2 104 17 207 32 195
LEUK 103 3 157 4 49 10 61
LUNG 149 3 157 19 231 28 170
LYMPH 318 3 157 30 365 43 262
MMYEL 103 0 0 4 49 8 49
MULT 23 0 0 0 0 1 6
Total 2006 24 1253 167 2033 281 1710

18-FEB-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS ONLY

Inst. Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
Member 1911 22 1148 154 1875 264 1607
AFFIL 141 1 52 16 195 29 177
CCOP/NCORP 1220 12 626 97 1181 170 1035
Non-SWOG 1663 28 1461 142 1729 222 1351
Total 4935 63 3287 409 4980 685 4170

18-FEB-2026 6:11

STUDIES OPENED THIS MONTH

ADMIN STUDYID STNAME REGTYPE Opened? Open Date
ERLYTX SN2426 cSCC, IC Met/Inop, Amivantamab v Cetuximab 1 Y 28-JAN-26

18-FEB-2026 6:11

STUDIES CLOSED THIS MONTH

ADMIN STUDYID STNAME REGTYPE Opened? Open Date
GU S2210 Pros, High Risk, BRCA, Neoadj Carbo 1 T 21-JAN-26
LEUK S1905 T-ALL/T-LBL, Rel/Ref, OBI-3424 1 N 15-FEB-26
LUNG S1933 NSCLC, Stg II-III, RT + Atezo 1 N 15-FEB-26
OTHER NRGBN011 Brain, Lomustine + Temo vs Temo 1 E 12-FEB-26
OTHER NRGBN011 Brain, Lomustine + Temo vs Temo 2 E 12-FEB-26
OTHER A071701 BRAIN, Met, Geno-guided trial 0 E 05-FEB-26
OTHER A071701 BRAIN, Met, Geno-guided trial 1 E 05-FEB-26

18-FEB-2026 6:11

STUDIES WITH 3 OR MORE REGISTRATIONS THIS WEEK

ADMIN STUDYID STNAME REGTYPE Registrations
BREAST S2206 Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva 1 10
LEUK MYELOMATCH MSRP for the NCI myeloMATCH Clinical Trials 1 9
BREAST S2212 Breast, TNBC, Neoadj Chemo + Pembro 1 9
LUNG LUNGMAP NSCLC, Adv, Master 1 8
SXQOL S2013 I-CHECKIT: ICI toxicity risk prediction study 1 7
LUNG LUNGMAP NSCLC, Adv, Master 2 4
LEUK MM1YA-S01 AML, High Risk, Age <60, 7+3 vs experimental 1 3
LEUK MYELOMATCH MSRP for the NCI myeloMATCH Clinical Trials 3 3
SXQOL S2205 ICE COMPRESS: Reduction of CIPN from Taxanes 1 3
BREAST S2206 Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva 2 3